Liminatus Pharma (LIMN) Times Interest Earned (2024 - 2026)
Liminatus Pharma (LIMN) posted Times Interest Earned of -$59.07 for Q1 2026, down 1239.66% sequentially from $5.18 in Q4 2025, and down 2482.31% YoY from $2.48 in Q1 2025.
Liminatus Pharma (LIMN) Times Interest Earned (2024 - 2026) Analysis & Trends
Liminatus Pharma has reported Times Interest Earned for 3 years, with the latest figure at -$59.07 in Q1 2026.
- Quarterly Times Interest Earned fell 2482.31% year-over-year to -$59.07 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $53.87 (up 1658.82% YoY) and the FY2025 annual result came in at -$1.27, up 87.12% from the prior year.
- Times Interest Earned declined to -$59.07 in Q1 2026 per LIMN's latest filing, from $5.18 in the prior quarter.
- Over five years, Times Interest Earned peaked at $5.18 in Q4 2025 and troughed at -$59.07 in Q1 2026.
- A 3-year average of -$16.15 and a median of -$8.82 in 2024 frame the typical range for Times Interest Earned.
- The sharpest annual moves came in 2025 and 2026: Times Interest Earned surged 905.4% in 2025, then sank 2482.31% in 2026.
- Over 3 years, Times Interest Earned stood at -$0.64 in 2024, then surged by 905.4% to $5.18 in 2025, then sank by 1239.66% to -$59.07 in 2026.
- According to Business Quant data, Times Interest Earned over the past three periods registered -$59.07, $5.18, and -$36.8 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.42 |
| 10 | Liminatus Pharma | 256.03 Mn | 256.03 Mn | - | -73.17 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -59.07 |
| Dec 31, 2025 | 5.18 |
| Sep 30, 2025 | -36.80 |
| Jun 30, 2025 | -17.95 |
| Mar 31, 2025 | -2.29 |
| Dec 31, 2024 | -0.64 |
| Sep 30, 2024 | -5.86 |
| Jun 30, 2024 | -11.77 |